Shifting the lines against central nervous system disorders

2020 full-year results and update on the progress of main programs

07/04/2021
Download PDF File (1443Ko)

THERANEXUS extends the capabilities of Neurolead, its active agent screening platform, to autophagy and neurological lysosomal storage disorders

09/03/2021
Download PDF File (326Ko)

Semi-annual liquidity contract summary - H2 2020

19/01/2021
Download PDF File (538Ko)

THERANEXUS presents an update on the progress of its main programs and announces its cash position as of 31 December 2020

18/01/2021
Download PDF File (538Ko)